Bausch + Lomb Corp
NYSE:BLCO

Watchlist Manager
Bausch + Lomb Corp Logo
Bausch + Lomb Corp
NYSE:BLCO
Watchlist
Price: 11.58 USD -5.08% Market Closed
Market Cap: 4.1B USD
Section:
Relative Value
Relative Value
Valuation Multiples
Multiples Across Competitors
See Also

Relative Value

The Relative Value of one BLCO stock under the Base Case scenario is 39.43 USD. Compared to the current market price of 11.58 USD, Bausch + Lomb Corp is Undervalued by 71%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

BLCO Relative Value
Base Case
39.43 USD
Undervaluation 71%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.8
P/S
P/S
Price to Sales
0.8
vs History
89
vs Industry
61
Median 3Y
1.4
Median 5Y
1.4
Industry
2.2
Forward
0.8
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
0
Median 3Y
-17.8
Median 5Y
-17.8
Industry
21.9
Forward
23.1
More Details
24.7
P/OCF
P/OCF
Price to OCF
24.7
vs History
48
vs Industry
15
Median 3Y
24.7
Median 5Y
24.7
Industry
14
More Details
73.1
P/FCFE
P/FCFE
Price to FCFE
73.1
vs History
12
vs Industry
40
Median 3Y
2.8
Median 5Y
2.8
Industry
19.7
More Details
0.6
P/B
P/B
Price to Book Value
0.6
vs History
92
vs Industry
67
Median 3Y
0.9
Median 5Y
0.9
Industry
2.1
More Details
1.8
EV/S
EV/S
Enterprise Value to Sales
1.8
vs History
89
vs Industry
46
Median 3Y
2.2
Median 5Y
2.2
Industry
2.3
Forward
1.7
More Details
3
EV/GP
EV/GP
Enterprise Value to Gross Profit
3
vs History
89
vs Industry
55
Median 3Y
3.7
Median 5Y
3.7
Industry
4.8
More Details
15.5
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
15.5
vs History
48
vs Industry
22
Median 3Y
15.5
Median 5Y
15.5
Industry
11.5
Forward
10.2
More Details
68.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
68.3
vs History
5
vs Industry
8
Median 3Y
47.7
Median 5Y
47.7
Industry
15.7
Forward
14.7
More Details
52.3
EV/OCF
EV/OCF
Enterprise Value to OCF
52.3
vs History
35
vs Industry
7
Median 3Y
46.6
Median 5Y
46.6
Industry
14
More Details
Negative
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
N/A
vs History
vs Industry
11
Median 3Y
-53.5
Median 5Y
-53.5
Industry
17.4
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
92
vs Industry
65
Median 3Y
0.8
Median 5Y
0.8
Industry
1.8
More Details

Multiples Across Competitors

BLCO Competitors Multiples
Bausch + Lomb Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
Market Cap P/S P/E EV/EBITDA EV/EBIT
CA
Bausch + Lomb Corp
NYSE:BLCO
4.1B USD 0.8 -11.3 15.5 68.3
CH
Alcon AG
SIX:ALC
34.3B CHF 4.2 37.5 17.3 32.7
JP
Hoya Corp
TSE:7741
5.9T JPY 6.8 29.1 17.9 21.4
DK
Coloplast A/S
CSE:COLO B
135.7B DKK 4.9 29.9 17.3 20.4
US
Align Technology Inc
NASDAQ:ALGN
13.1B USD 3.3 32 15.2 18.8
UK
ConvaTec Group PLC
LSE:CTEC
5.9B GBP 3.4 41.3 210.1 343.7
CH
Ypsomed Holding AG
SIX:YPSN
5.6B CHF 7.4 63.5 30.5 52.2
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
45.9B CNY 13.1 32.9 28.4 28.4
US
Merit Medical Systems Inc
NASDAQ:MMSI
5.5B USD 4 44.9 20.7 36.2
US
Lantheus Holdings Inc
NASDAQ:LNTH
5.5B USD 3.6 21.5 10 11.4
KR
HLB Inc
KOSDAQ:028300
6.6T KRW 88.4 -35 -62.1 -58.7
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CA
Bausch + Lomb Corp
NYSE:BLCO
Average EV/EBITDA: 38.3
15.5
19%
0.8
CH
Alcon AG
SIX:ALC
17.3
10%
1.7
JP
Hoya Corp
TSE:7741
17.9
9%
2
DK
Coloplast A/S
CSE:COLO B
17.3
9%
1.9
US
Align Technology Inc
NASDAQ:ALGN
15.2
15%
1
UK
ConvaTec Group PLC
LSE:CTEC
210.1
11%
19.1
CH
Ypsomed Holding AG
SIX:YPSN
30.5
31%
1
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
28.4
18%
1.6
US
Merit Medical Systems Inc
NASDAQ:MMSI
20.7
12%
1.7
US
Lantheus Holdings Inc
NASDAQ:LNTH
10
21%
0.5
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -62.1 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CA
Bausch + Lomb Corp
NYSE:BLCO
Average EV/EBIT: 63.3
68.3
55%
1.2
CH
Alcon AG
SIX:ALC
32.7
25%
1.3
JP
Hoya Corp
TSE:7741
21.4
N/A N/A
DK
Coloplast A/S
CSE:COLO B
20.4
9%
2.3
US
Align Technology Inc
NASDAQ:ALGN
18.8
17%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
343.7
22%
15.6
CH
Ypsomed Holding AG
SIX:YPSN
52.2
40%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
28.4
16%
1.8
US
Merit Medical Systems Inc
NASDAQ:MMSI
36.2
28%
1.3
US
Lantheus Holdings Inc
NASDAQ:LNTH
11.4
22%
0.5
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -58.7 N/A N/A

See Also

Summary
BLCO intrinsic value, competitors valuation, and company profile.
DCF Valuation
BLCO stock valuation using Discount Cash Flow valuation method.
Relative Valuation
BLCO stock valuation using valuation multiples.
Wall Street Estimates
BLCO price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
BLCO stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 262,500+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.